国际眼科杂志Issue(3)：460-463,4.DOI:10.3980/j.issn.1672-5123.2014.03.21
早产儿视网膜病变药物治疗研究新进展
Recent advances of medicine treatment research in retinopathy of prematurity
郑玲 1冯光强1
作者信息
- 1. 510000 中国广东省广州市，广州医科大学
- 折叠
摘要
Abstract
Retinopathy of prematurity ( ROP) is a vasoproliferative retinopathy with unmatured and low weight infants. Now in domestic, the main treatment methods are cryotherapy and laser coagulation, there are some medication treatment researches and fundamental researches that have been reported in recent years.This review describes the application of bevacizumab, ranibizumab and other research-based drugs in new progress of the treatment study for ROP.关键词
早产儿视网膜病变/血管内皮细胞生长因子/药物治疗/剂量/实验研究Key words
retinopathy of prematurity/vascular endothelial growth factor/medication treatment/dosage/experimental study引用本文复制引用
郑玲,冯光强..早产儿视网膜病变药物治疗研究新进展[J].国际眼科杂志,2014,(3):460-463,4.
